Pasar al contenido principal

BIOSENSORES MULTIANALITO INTELIGENTES PARA EL DIAGNOSTICO PRECOZ DEL TRASTORNO DEL ESPECTRO AUTISTA

PID2023-150844OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Tetrahedral DNA nanostructures, graphene and carbon nanodots-based electrochemiluminescent biosensor for BRCA1 gene mutation detection

  • García-Fernández, Daniel
  • Gutiérrez-Gálvez, Laura
  • López-Diego, David
  • Luna, Mónica
  • Torres, Íñigo
  • Zamora, Félix
  • Solera, Jesús
  • García-Mendiola, Tania
  • Lorenzo, Encarnación
In this study, we present a novel electrochemiluminescent DNA biosensor designed for detecting breast cancer type 1 (BRCA1) gene mutations. The biosensor integrates graphene nanosheets (Graph-NS), tetrahedral DNA nanostructures (TDNs), and carbon nanodots (CNDs) to enhance sensitivity and specificity. Graph-NS are employed to structure the transducer and serve as a platform for DNA immobilization. TDNs are engineered with a BRCA1 gene-specific capture probe located at the apex (TDN-BRCA1), facilitating efficient biorecognition. Additionally, the basal vertices of TDNs are functionalized with amino groups, enabling their attachment to the CSPE/Graph-NS surface via amino-graphene interaction. This platform effectively identifies single-base mutations in the BRCA1 gene utilizing synthesized CNDs as a coreactant and [Ru(bpy)3]2+ as the luminophore through the coreactant pathway. The developed biosensor demonstrates exceptional sensitivity and can detect a single mutation in the BRCA1 gene. Furthermore, it has been successfully validated in real samples obtained from breast cancer patients, showcasing a remarkable detection limit of 1.41 aM., The Spanish Ministry of Economy and Competitiveness has financially supported this work (PID2020-116728RB-I00, PID2023-150844OB-I00, RED2022-134120-T and TED2021-129738B–I00). Spanish Ministry of Universities supported Laura Gutiérrez-Gálvez with a FPU (FPU19/06309). European Union, through Autonomous Community of Madrid supported Daniel García-Fernández with a Programa Investigo grant in from the Plan de Recuperación, Transformación y Resiliencia– NextGenerationEU (09-PIN1-00013.4/2022-Puesto 83). The authors acknowledge the support of the EU and Horizon 2020 through Instruct Proposal PID: 21859, and the CRIOMECORR project (ESFRI-2019-01-CSIC-16) to the cryoEM CNB-CSIC facility. The authors also appreciate the service from the MiNa Laboratory at IMN, and funding from EU (FEDER, FSE), MINECO (project CSIC13-4E-1794) and CM (project S2018/NMT-4291 TEC2SPACE)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Advancing diagnostics with BODIPY-bismuthene DNA biosensors

  • Gutiérrez-Gálvez, Laura
  • Enebral-Romero, Estefanía
  • Valle Amores, Miguel Ángel
  • Pina Coronado, Clara
  • Torres, Iñigo
  • López-Diego, David
  • Luna, Mónica
  • Fraile, Alberto
  • Zamora, Félix
  • Alemán, José
  • Álvarez, Jesús
  • Capitán, M. J.
  • Lorenzo, Encarnación
  • García-Mendiola, Tania
In this work, an electrochemical biosensor is prepared based on few-layer bismuthene hexagons (FLBHs) and a water-soluble BODIPY (BDP) derivative (BDP-NaSO3) for early infection diagnosis. In particular, the detection in advance of a virus sequence in nasopharyngeal swab samples was developed. The combination of the FLBHs and BDP-NaSO3 facilitates the direct, sensitive, and specific detection of gene viruses without the need for any prior amplification step. This work demonstrates that the FLBHs provide an improved electrochemical platform for immobilizing thiolated DNA capture probes that increase the sensitivity of the biosensor, while BDP-NaSO3 serves as a newly powerful electrochemical indicator of the hybridization event. As a proof of concept, SARS-CoV-2 was selected as the model virus. The developed biosensor demonstrated selective, rapid, and straightforward detection of the specific sequence RNA-dependent RNA-polymerase (RdRp) of SARS-CoV-2 with a detection limit of 4.97 fM and a linear range from 16.6 fM to 100 fM. Furthermore, this platform successfully detects the virus directly in nasopharyngeal swab samples with a viral load of at least 19 Cts without being subjected to any prior amplification stage. Finally, the high stability of the biosensor response, which has been working under ambient conditions for over one month, the selectivity and rapidity for specific virus detection, and the requirement of low-volume samples for the determination are remarkable characteristics that make it ideal for its potential application in clinical diagnosis in point-of-care settings., This work was financially supported by the Spanish Ministry of Economy and Competitiveness (PID2020-116728RB-I00, RED2022-134120-T, PID2023-150844OB-I00, PID2022- 138908NB-C31, and PID2021-122299NB-I00), the Community of Madrid (REACT-UE NANOCOV-CM and Y2020/NMT6469), the Spanish Ministry of Science, Innovation and Universities (TED2021-129738B-I00, TED2021-130470B-I00, and TED2021- 129999B-C32) and the “María de Maeztu” Programme for Units of Excellence in R&D, CEX2023-001316-M. Laura Gutiérrez-Gálvez gratefully acknowledges the financial support of a Formación del Profesorado Universitario (FPU) grant from the Spanish Ministry of Universities (FPU19/06309). Estefanía Enebral-Romero received financial support from the “Nanotecnología para detección del SARS-CoV-2 y sus variantes, NANOCOV” project and a contract as a pre-doctoral researcher funded by a grant CEX2020-001039-S, supported by MCIN/AEI/10.13039/501100011033. We also acknowledge María U. González and Raquel Alvaro for their help with fluorescence microscopy and EDAX mapping, respectively, and the services of the MiNa Laboratory at IMN and funding from CM (project S2018/NMT-4291 TEC2SPACE), MINECO (project CSIC13-4E-1794) and the EU (FEDER, FSE). We also acknowledge the “Servicio de Microbiología, Hospital Universitario Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)” for providing the clinical samples. We acknowledge the support from the “(MAD2D-CM)-UAM” project funded by Comunidad de Madrid by the Recovery, Transformation and Resilience Plan and by NextGenerationEU from the European Union., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

MoS₂-DNA tetrahedral bioconjugate for high-performance DNA biosensors: application in viral infection diagnostics

  • Enebral-Romero, Estefanía
  • Martínez-Periñán, Emiliano
  • López-Diego, David
  • Luna, Mónica
  • Garrido, Marina
  • Navío, Cristina
  • Pérez, Emilio M.
  • Lorenzo, Encarnación
  • García-Mendiola, Tania
An electrochemical DNA biosensor is presented for early viral infection detection, integrating molybdenum disulphide (MoS₂), tetrahedral DNA nanostructures (TDNs), and thionine-modified carbon nanodots (CNDsTy). The innovation of this work lies in the first-time integration of these nanomaterials for the preparation of a bioconjugate, whose synergy enables the biosensor's functionality. MoS₂ anchors the TDNs, which carry the capture probe for virus identification via genetic code recognition. CNDsTy allow the electrochemical detection based on their different affinity for single-stranded (ssDNA) and double-stranded DNA (dsDNA), enabling hybridization event identification. The biosensor achieves high sensitivity (detection limit of 5.00 fM) and can distinguish viral loads, validated with the SARS-CoV-2 ORF1ab sequence in human nasopharyngeal samples., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. The research leading to these results received funding from Spanish Ministry of Economy and Competitiveness (PID2020-116728RB-I00, RED2022-134120-T, and PID2023-150844OB-I00), Community of Madrid (REACT-UE NANOCOV-CM, (MAD2D-CM)-IMDEA and S2018/NMT-4291 TEC2SPACE), Spanish Ministry of Science, Innovation and Universities (TED2021-129738B-I00, PID2020-116661RB-I00, and CEX2020-001039-S), the Recovery, Transformation and Resilience Plan, the European Union (NextGenerationEU and FEDER, FSE), and by MINECO (CSIC13-4E-1794)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dendrimer-based DNA biosensor for HIV virus detection

  • Enebral Romero, Estefanía
  • Toldos-Torres, Marta
  • López-Diego, David
  • Luna, Mónica
  • Failde, Marta
  • González-Tobío, Brais
  • Zamora, Félix
  • Falces-Romero, Iker
  • Montes, María Luisa
  • García-Mendiola, Tania
In this work, we propose an innovative electrochemical DNA biosensor for the early, rapid, selective, and sensitive detection of the human immunodeficiency virus (HIV) based on its genetic code. This platform is based on the integration of few-layer bismuthene (FLB) which provides a nanostructured surface and facilitates the anchoring of the DNA dendrimer which incorporates the biorecognition element (a capture probe complementary to the HIV-specific DNA sequence). The hybridization between the capture probe and the specific HIV target sequence is detected using Azure A (AA) as a redox indicator. The dendrimer-based DNA biosensor selectively detects HIV from 10.0 fM to 10.0 pM, exhibit a low detection limit of 3.03 fM and a 60-day stability, and has been validated using plasma samples from infected patients with varying viral loads., This work was financially supported by the Spanish Ministry of Science, Innovation and Universities through the following projects: MCIU-25-RED2024-153970-T, PID2023-150844OB-I00, RED2022-134120-T, PID2022-138908NB-C31, PDC2021-120782-C21, and TED2021-129738B-I00. F.Z. acknowledges support from Spanish Ministry of Science, Innovation and Universities with the grant PID2022-138908NB-C31, from the Community of Madrid, the European Union's NextGenerationEU programme and the Recovery, Transformation and Resilience Plan, with the “MAD2D-CM-UAM” project, and from the Spanish Ministry of Science and Innovation through the “María de Maeztu” Programme for Units of Excellence in R&D (CEX2023-001316-M). B. G. acknowledges the financial support from the “Ayuda para Contratos Predoctorales para la Formación de Doctores” program of MICINN (PRE2020-093162). Additional support was provided by the European Innovation Council under grant agreement 101047081 (EVA). We also acknowledge the MiNa Laboratory at IMN for technical support, and funding from the MCIN/AEI/10.13039/501100011033, EU (FEDER, FSE), and Next Generation EU/PRTR (EQC2021-006944-P)